Bora CDMO Bora CDMO

X

Find Olitigaltin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

GB0139
Also known as: Td-139, Td139, 1450824-22-2, Td 139, Olitigaltin, Gb0139
Molecular Formula
C28H30F2N6O8S
Molecular Weight
648.6  g/mol
InChI Key
YGIDGBAHDZEYMT-MQFIMZJJSA-N
FDA UNII
60Y0GUO72B

Olitigaltin is an inhaled, small molecule inhibitor of galectin-3 (Gal-3), with potential anti-fibrotic activity. Upon administration, olitigaltin inhibits the activity of Gal-3. This may prevent the activation of alveolar macrophages and fibroblasts, and the resulting fibrosis in the lungs. Gal-3, a beta-galactoside-binding lectin, is expressed in multiple cell types including macrophages, fibroblasts, activated T-lymphocytes and epithelial cells. It is upregulated in fibrotic lung diseases including idiopathic pulmonary fibrosis (IPF) and interstitial pneumonia associated with collagen vascular disease (CVD-IP), and plays an important role in fibrosis in multiple organs. It is also often dysregulated in cancers, and may play a role in angiogenesis, cell proliferation and cell survival.
1 2D Structure

GB0139

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,5-diol
2.1.2 InChI
InChI=1S/C28H30F2N6O8S/c29-15-5-1-3-13(7-15)17-9-35(33-31-17)21-23(39)19(11-37)43-27(25(21)41)45-28-26(42)22(24(40)20(12-38)44-28)36-10-18(32-34-36)14-4-2-6-16(30)8-14/h1-10,19-28,37-42H,11-12H2/t19-,20-,21+,22+,23+,24+,25-,26-,27+,28+/m1/s1
2.1.3 InChI Key
YGIDGBAHDZEYMT-MQFIMZJJSA-N
2.1.4 Canonical SMILES
C1=CC(=CC(=C1)F)C2=CN(N=N2)C3C(C(OC(C3O)SC4C(C(C(C(O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O
2.1.5 Isomeric SMILES
C1=CC(=CC(=C1)F)C2=CN(N=N2)[C@H]3[C@H]([C@H](O[C@H]([C@@H]3O)S[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O
2.2 Other Identifiers
2.2.1 UNII
60Y0GUO72B
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Gb 0139

2. Gb-0139

3. Gb0139

4. Td-139

2.3.2 Depositor-Supplied Synonyms

1. Td-139

2. Td139

3. 1450824-22-2

4. Td 139

5. Olitigaltin

6. Gb0139

7. Olitigaltin [usan]

8. Gb-0139

9. 60y0guo72b

10. (2s,3r,4s,5r,6r)-4-[4-(3-fluorophenyl)triazol-1-yl]-2-[(2s,3r,4s,5r,6r)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,5-diol

11. (2r,2'r,3r,3'r,4s,4's,5r,5'r,6s,6's)-6,6'-thiobis(4-(4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl)-2-(hydroxymethyl)tetrahydro-2h-pyran-3,5-diol)

12. Unii-60y0guo72b

13. Td2

14. Olitigaltin [inn]

15. Gal-3 Inhibitor Gb0139

16. Galectin-3 Inhibitor Gb0139

17. Chembl4297442

18. Schembl15657269

19. Td 139 [who-dd]

20. Gtpl12148

21. Ex-a1688

22. Who 12032

23. Zinc208938373

24. Cs-6265

25. Db12895

26. Gb 0139

27. Ac-35516

28. Beta-d-galactopyranoside, 3-deoxy-3-(4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl)-beta-d-galactopyranosyl 3-deoxy-3-(4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl)-1-thio-

29. Bs-15429

30. Bt173009

31. Hy-19940

32. C72753

33. A857944

34. Q27263259

35. Bis-(3-deoxy-3-(3-fluorophenyl-1h-1,2,3-triazol-1-yl)-beta-d-galactopyranosyl)-sulfane

36. .beta.-d-galactopyranoside, 3-deoxy-3-(4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl)-.beta.-d-galactopyranosyl 3-deoxy-3-(4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl)-1-thio-

37. 3,3'-dideoxy-3,3'-bis-(4-(3-fluorophenyl)-1h-1,2,3-triazol-1-yl)-1,1'-sulfanediyl-di-.beta.- D-galactopyranoside

38. Bis(3-deoxy-3-(3-fluorophenyl-1h-1,2,3-triazol-1-yl)-.beta.-d-galactopyranosyl)sulfane

2.4 Create Date
2014-05-26
3 Chemical and Physical Properties
Molecular Weight 648.6 g/mol
Molecular Formula C28H30F2N6O8S
XLogP30.2
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count15
Rotatable Bond Count8
Exact Mass648.18138943 g/mol
Monoisotopic Mass648.18138943 g/mol
Topological Polar Surface Area227 Ų
Heavy Atom Count45
Formal Charge0
Complexity903
Isotope Atom Count0
Defined Atom Stereocenter Count10
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY